Related Experiment Video
Updated: Apr 26, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
22.1K
Morbidity and mortality in sarcoidosis
1Department of Internal Medicine/Pulmonary and Critical Care Medicine, University of Iowa, Iowa City, Iowa, USA.
Current Opinion in Pulmonary Medicine
|July 17, 2014
Summary
Morbidity in chronic sarcoidosis is significant and multifactorial, impacting hospitalizations and healthcare. While sarcoidosis mortality is infrequent, recent data suggests it may be increasing, necessitating further research.
Area of Science:
- Pulmonary Medicine
- Immunology
- Internal Medicine
Background:
- Chronic sarcoidosis presents complex challenges with multiple comorbidities.
- Understanding morbidity and mortality is crucial for effective sarcoidosis management and treatment selection.
Purpose of the Study:
- To review emerging knowledge on morbidity and mortality in sarcoidosis.
- To identify key factors contributing to poor outcomes in sarcoidosis patients.
Main Methods:
- Literature review of recent population studies and research on sarcoidosis.
- Analysis of trends in sarcoidosis-related hospitalizations and healthcare resource utilization.
Main Results:
- Sarcoidosis contributes to significant morbidity, evidenced by increased hospitalizations and healthcare use.
- Mortality from sarcoidosis, though infrequent (1-5%), shows a potential increasing trend.
- Morbidity stems from granulomatous inflammation, treatment side effects, and psychosocial impacts, with recent focus on cardiopulmonary, bone health, and aging.
Conclusions:
- Morbidity in sarcoidosis is substantial and influenced by multiple factors.
- While sarcoidosis mortality rates are low, an upward trend warrants attention and further investigation.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:29Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
01:23Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:28Pulmonary Tuberculosis II
2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
01:28Fungal Phylum Microsporidia
778
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
778